English Convenience Translation - the German language is decisive
Annual General Meeting of BioNTech SE on 17 May 2024
Proposal on the appropriation of balance sheet profit for the 2023 financial year
The Management Board proposes to carry forward the balance sheet profit of BioNTech SE from the past 2023 financial year in the amount of EUR 9.360.948.811,25 in full to new account.
Mainz, in March 2024
BioNTech SE
Management Board
_________________________________ | _________________________________ |
Prof. Dr. med. Uğur Şahin | Jens Holstein |
_________________________________ | _________________________________ |
Sean Marett | Dr. Sierk Poetting |
_________________________________ | _________________________________ |
Ryan Richardson | Dr. James Ryan |
_________________________________
Prof. Dr. med. Özlem Türeci
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
BioNTech SE published this content on 03 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 May 2024 00:20:07 UTC.